Our pipeline effectively targets high-need medical disorders

Ksilink’s objective is to deliver clinical candidates through proprietary programs or through strategic collaborations.

Our phenotypic drug discovery engine provides holistic insights into complex human disease biology and allows for high-througput screening of our patient-based cellular systems. We generate hit candidates supported by human proof of concept and robust target hypotheses, with the goal of advancing them into preclinical development and ultimately toward clinical candidate nomination.

Our pipeline is completed with research driven programs with support from national and EU consortia to become next generation drug discovery programs.